A Phase I Study of Lenalidomide Plus a Next Generation Anti-CD20 Antibody, Obinutuzumab, in Relapsed Indolent Lymphoma

Nathan H. Fowler, Raisa M. Pinto, Chan Yoon Cheah, Sattva S. Neelapu, Francesco Turturro, Fredrick B. Hagemeister, Jorge E. Romaguera, Michelle A Fanale, Luis E. Fayad, Sheryl G. Forbes, Janine Khan, Lei Feng, Felipe Samaniego, Loretta J. Nastoupil

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

Original languageEnglish
Number of pages3
Issue number23
Publication statusPublished - 3 Dec 2015
Externally publishedYes
Event57th Annual Meeting of the American-Society-of-Hematology - Orlando, United States
Duration: 5 Dec 20158 Dec 2015

Cite this